Navigation Links
Significant Pre-Clinical Data in Acute Lung Injury
Date:9/9/2012

The Company possesses multiple proprietary siRNA delivery technology platforms including AtuPLEX™, DACC and DBTC. AtuPLEX enables the broad functional delivery of siRNA molecules to targeted diseased tissues and cells, while increasing their bioavailability and intracellular uptake. The DACC delivery system allows functional delivery of siRNA molecules selectively to the lung endothelium with a long duration of target mRNA and protein knock-down. The DBTC delivery system enables functional delivery of siRNA molecules selectively to liver cells including hepatocytes. Additionally, the Company has a platform of novel siRNA molecules based around its AtuRNAi chemical modification technology, which provides a number of advantages over conventional siRNA molecules. Silence's unique RNAi assets also include structural features for RNAi molecules and specific design rules for increased potency and reduced off-target effects of siRNA sequences.

The Company's lead internal drug candidate is Atu027, a liposomal formulation in clinical development for systemic cancer indications and one of the most clinically advanced RNAi therapeutic candidates in the area of oncology. Atu027 incorporates two of the Company's technologies, AtuRNAi and AtuPLEX. Silence is currently conducting an open-label, single-centre, dose-escalation Phase I study with Atu027 in patients with advanced solid tumors involving single, as well as repeated, intravenous administration. Encouraging interim safety and pharmacokinetic data were presented at the American Society of Clinical Oncology Annual Meeting in June 2011. The study is expected to be completed in the first half of 2012.

The Company's RNAi therapeutic platform has received key validation through multiple partnerships with pharmaceutical companies including AstraZeneca, Dainippon Sumitomo, Pfizer/Quark, and Novartis/Quark. Silence is actively pursuing the establishment of additional partnerships. Silence The
'/>"/>

SOURCE Silence Therapeutics Plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Epigenomics Presents Significant Opportunities for Investment and Product Development, According to New Biotech Market Research
2. Latest Drug Sales Data: Loss of Patent Protection Has Significant Effect, According to Drugs.com
3. Patient Advocate Foundation Receives Significant Support to Aid Non-Squamous Non-Small Cell Lung Cancer Patients through the Co-Pay Relief Program
4. Cambrex Announces Significant New Supply Agreement
5. Wound Care Management Market to 2018 - Advanced Wound Care Modalities and an Expanding Patient Base Create Significant Growth Opportunities in Emerging Countries
6. Huntzinger Management Group, Inc., (HMG) Reporting Significant Growth in 2012
7. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
8. North Dakotas Stop-Sale System Achieves Significant Results In Battle Against Meth
9. Floridas Stop-Sale System Achieves Significant Results In Battle Against Meth
10. Nebraska Stop-Sale System Achieves Significant Results In Battle Against Meth
11. Texas Stop-Sale System Achieves Significant Results In Battle Against Meth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Inc. (OTCQB:ECIA), a medical device company owning patented surgical ... invasive surgery, today announced financial results for its fiscal ... 2015. The Company posted quarterly net revenue ... $349 thousand, or $(0.03) per share. These results compare ... loss of $1.453 million, or $(0.14) per share, in ...
(Date:5/27/2015)... , May 27, 2015 Biosensors International Group, ... Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer ... its fourth fiscal quarter ("Q4 FY15") and fiscal full ... Highlights and Recent Developments: , Q4 FY15: ... from the fourth quarter of Fiscal Year 2014 ("Q4 ...
(Date:5/27/2015)... , May 27, 2015 AtCor Medical ... SphygmoCor ® system which measures central aortic blood ... a panel US medical experts for physicians on the ... patient care. The article, "Clinical Use of Pulse ... American Artery " was published in the Journal of ...
Breaking Medicine Technology:Encision Reports Fourth Quarter And Fiscal Year 2015 Results 2Encision Reports Fourth Quarter And Fiscal Year 2015 Results 3Encision Reports Fourth Quarter And Fiscal Year 2015 Results 4Encision Reports Fourth Quarter And Fiscal Year 2015 Results 5Encision Reports Fourth Quarter And Fiscal Year 2015 Results 6Biosensors Reports Financial Results for Fiscal Year 2015 2Biosensors Reports Financial Results for Fiscal Year 2015 3Biosensors Reports Financial Results for Fiscal Year 2015 4Biosensors Reports Financial Results for Fiscal Year 2015 5Biosensors Reports Financial Results for Fiscal Year 2015 6Biosensors Reports Financial Results for Fiscal Year 2015 7Expert panel publishes guidance for central aortic pressure waveform analysis in patient care 2Expert panel publishes guidance for central aortic pressure waveform analysis in patient care 3
(Date:5/27/2015)... May 27, 2015 According to research ... Southwestern Medical Center at Dallas some migraine patients have ... CTS and migraine headache apparently also have some shared ... of obesity, people with a history of diabetes and/or ... in Asians, and CTS in particular was less common ...
(Date:5/27/2015)... The Advanced Fertility Center of Chicago announces that their ... better serve the needs of couples in Chicagoland. The ... Northwest side of the city at 4920 North Central Ave., ... the Chicago office at (773) 794–1818. This is the ... The other 2 offices are in Gurnee and Crystal ...
(Date:5/26/2015)... Carey Danis & Lowe ... lawsuit . The suit pertains to AndroGel, a testosterone ... in late April 2015, and a court document relating ... court in mid-May.¹ , Testosterone gel lawsuits are being ... District of Illinois. The multidistrict litigation (MDL) is In ...
(Date:5/26/2015)... 2015 Securityhunter has been ... the United States Department of Health and Human Services ... The MATOC was awarded through the General Services Administration ... the PSC, which is a fee-for-service agency. The award ... options, and is an enterprise–wide physical security and security ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Forex Income ... interested in improving their results trading in the foreign ... trader Russ Horn, utilizes 10 customer indicators to help ... consistency. , "As usual, Russ Horn's latest trading system ... Forex trading community," reports Tiffany Hendricks, senior product reviewer ...
Breaking Medicine News(10 mins):Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 2Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 3Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 4Health News:The Advanced Fertility Center of Chicago Opens a New Fertility Office Location in Chicago 2Health News:Carey Danis & Lowe Comments on Recently Filed Testosterone Gel Lawsuit 2Health News:Securityhunter Has Been Awarded a Multiple Award Task Order Contract (MATOC) by the Department of Health and Human Services 2Health News:Forex Income Boss - Review Of Russ Horn's New FX Trading System Released 2
... Universities of Warwick, Edinburgh, Dundee and the Czech Republics ... compound that is up to 80 times more powerful ... light activation to kill cancer cells in much ... compound known as trans, trans, trans- [Pt(N3)2(OH)2(NH3)(py)], or ...
... Inc.,(Amex: PLC ) announced today that it has ... the way for the Company to begin,its initial launch ... to initiate a limited launch of RenalGuard(TM) in the ... recognize the benefits of,utilizing the unique fluid balancing capabilities ...
... HealthSouth,Corporation (NYSE: HLS ) announced today that its ... $16.25 per share on its 6.5%,Series A Convertible Perpetual ... record on January 2, 2008., About HealthSouth, ... Operating in 27 states across the country and in,Puerto ...
... The Greater Detroit Area Health,Council,s (GDAHC) ... partnership,with the American Diabetes Association, sanofi-aventis, and ... program to help people with,diabetes better manage ... connect,employers, community organizations and labor groups with ...
... linked, research suggests , FRIDAY, Dec. 21 (HealthDay News) -- ... diabetes, concludes a University of Pennsylvania School of Medicine study ... . , It found that providing depression care management to ... death over five years by about 50 percent. , "Depression ...
... Makes Results from Burdick(R) and, Quinton(R) branded products from Cardiac Science ... ... 5.0, BOTHELL, Wash. and MELVILLE, N.Y., ... provider of cardiac,monitoring, defibrillation and rehabilitative products, and Henry Schein,Medical Systems, ...
Cached Medicine News:Health News:Light powered platinum more targeted and 80 times more powerful than similar cancer treatments 2Health News:PLC Systems Receives CE Mark Approval for RenalGuard(TM) 2Health News:PLC Systems Receives CE Mark Approval for RenalGuard(TM) 3Health News:PLC Systems Receives CE Mark Approval for RenalGuard(TM) 4Health News:HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock 2Health News:GDAHC Save Lives Save Dollars Initiative Launches Pilot Program for Diabetes Care Management 2Health News:GDAHC Save Lives Save Dollars Initiative Launches Pilot Program for Diabetes Care Management 3Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems' MicroMD(R) EMR 5.0 2Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems' MicroMD(R) EMR 5.0 3Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems' MicroMD(R) EMR 5.0 4Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems' MicroMD(R) EMR 5.0 5
The WADiana Compact is a fully automated immuno-haematology analyser, easy to use with maximum security including clot detection and ensuring no contamination....
... PK7200 works on patented microplate agglutination ... testing system for donor ABO/Rh testing. PK7200 ... syphilis and cytomegalovirus antibody detection. The Automated ... along with the proven reliability that for ...
... Tecan Haemotyper is an automated ... The Tecan Haemotyper combines a ... platform with the DiaMed agglutination ... process DiaMed-ID cards and microplates ...
... the "Reversed" shoulder prosthesis has been used ... More recently, an ever-growing number of surgeons ... champion this prosthesis and the associated surgical ... technology is the result of nearly fifteen ...
Medicine Products: